|
ZFP91 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.916200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.716500E-03 |
| Normal-vs-Stage2 |
2.965200E-01 |
| Normal-vs-Stage3 |
2.541400E-01 |
| Normal-vs-Stage4 |
7.770300E-02 |
| Stage1-vs-Stage2 |
7.145600E-01 |
| Stage1-vs-Stage3 |
7.650000E-01 |
| Stage1-vs-Stage4 |
4.226000E-01 |
| Stage2-vs-Stage3 |
9.340200E-01 |
| Stage2-vs-Stage4 |
3.114600E-01 |
| Stage3-vs-Stage4 |
3.831800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.801600E-03 |
| Normal-vs-AfricanAmerican |
1.907190E-01 |
| Normal-vs-Asian |
1.273180E-01 |
| Caucasian-vs-AfricanAmerican |
5.542200E-01 |
| Caucasian-vs-Asian |
5.609200E-01 |
| AfricanAmerican-vs-Asian |
4.207800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.801700E-04 |
| Normal-vs-Female |
9.806800E-01 |
| Male-vs-Female |
2.338200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.775700E-03 |
| Normal-vs-Extreme_Weight |
2.355000E-04 |
| Normal-vs-Obese |
8.081800E-01 |
| Normal-vs-Extreme_Obese |
1.554030E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.298000E-01 |
| Normal_Weight-vs-Obese |
3.801700E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.529400E-01 |
| Extreme_Weight-vs-Obese |
1.246270E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.155000E-01 |
| Obese-vs-Extreme_Obese |
2.674800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.020200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.021200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.845600E-04 |
| Normal-vs-Age(81-100Yrs) |
2.055100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.893400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.261010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.427500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.216100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.165560E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.595600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.585580E-02 |
| Normal-VS-Type2 PRCC |
2.417800E-03 |
| Normal-VS-KIRP CIMP |
7.685400E-01 |
| Normal-VS-Unclassified PRCC |
8.207600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.564800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.869600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.359810E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.136220E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.033700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.907400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.021600E-04 |
| Normal-vs-N1 |
9.982200E-01 |
| Normal-vs-N2 |
2.446800E-01 |
| N0-vs-N1 |
6.458100E-02 |
| N0-vs-N2 |
8.555200E-01 |
| N1-vs-N2 |
3.496200E-01 |
|
|
